FDA
FDA Declares EUA for Veterinary Drugs to Protect U.S. Food Supply From Screwworm
The FDA grants EUA for animal drugs to treat or prevent New World screwworm in response to protect food supply.
AUGUST 20, 2025
Skincare Products Recalled Because of B. cepacia Contamination
The FDA announced a recall of individual lots of products made by DermaRite Industries due to microbial ...
AUGUST 11, 2025
FDA Lifts Pause on Ixchiq Chikungunya Vaccine in People 60 and Up
The Ixchiq chikungunya vaccine is now available for people 60 years of age and older, after the FDA had paused all ...
AUGUST 7, 2025
FDA Updates Opioid Labeling Requirements to Reflect Long-Term Risks
The FDA announced major changes to its opioid pain medication labeling regulations that better emphasize and ...
AUGUST 7, 2025
FDA Expands Imovax Rabies Vaccine PrEP Regimen Options
The FDA has expanded the regimen options for Sanofi’s Imovax Rabies vaccine for PrEP to include a two-dose ...
JULY 29, 2025
Salmonella Outbreak Linked to Frozen Sprouted Beans Hospitalizes 4
An outbreak strain of Salmonella Anatum linked to frozen sprouted beans has sickened 11 people and hospitalized ...
JULY 24, 2025
FDA Approves Spikevax COVID Shot in Children at Increased Risk
The FDA approved Moderna’s COVID-19 vaccine, Spikevax, in children between the ages of 6 months and 11 years ...
JULY 15, 2025
Senate Committee to Vote Next Week on Top NIH, FDA Posts
The Senate’s Health, Education, Labor and Pensions Committee will vote Thursday, March 13, 2025, on the ...
MARCH 10, 2025
FDA Vaccine Advisory Committee Meeting Canceled
With no explanation, the FDA canceled the meeting of VRBPAC, scheduled to discuss the makeup of the 2025-2026 ...
FEBRUARY 27, 2025
FDA Addresses Risk for Enteric Viruses From Berries
The FDA discusses strategy aimed at reducing the risk for contamination of fresh and frozen berries with enteric ...
JANUARY 24, 2025
RSV Burden High Among U.S. Children
The burden of RSV remains high among U.S. children, and more efforts are needed to address gaps in data regarding ...
DECEMBER 18, 2024
FDA Grants Breakthrough Device Designation to New Sepsis Test
The FDA has granted Breakthrough Device designation to a new rapid diagnostic blood test for sepsis (MeMed ...
DECEMBER 10, 2024
